Peptides for Weight Loss: GLP-1, GH Secretagogues, and Fat-Loss Protocols

The Medical Weight-Loss Landscape

Peptide-based medicine has changed what physician-supervised weight loss looks like. Two distinct categories are used clinically: GLP-1 receptor agonists, which reduce appetite and food intake, and GH-secretagogue peptides, which influence fat metabolism and help protect lean mass. This guide covers overall weight loss; for the narrower question of visceral (belly) fat specifically, see our dedicated guide to peptides for visceral belly fat.

GLP-1 Agonists: Semaglutide and Tirzepatide

Semaglutide and tirzepatide are peptide-based medications that mimic gut hormones to reduce appetite. In the STEP 1 trial, once-weekly semaglutide produced substantial, sustained weight loss versus placebo,[1 and tirzepatide showed even larger reductions in the SURMOUNT-1 trial.[2 Both work through GLP-1 signaling pathways that regulate appetite and satiety.[3

Nutrition still does much of the work. Our semaglutide diet guide covers how to structure eating for the best results on these medications.

GH Secretagogues and Fat Metabolism

GH-secretagogue peptides take a different route. Tesamorelin has been shown to reduce visceral adipose tissue in controlled trials,[4 and growth-hormone therapy in abdominally obese men has been shown to reduce abdominal fat mass.[5 These peptides are often considered when the goal is fat distribution and body composition rather than total scale weight alone.

Protecting Lean Mass During Weight Loss

Rapid weight loss can cost muscle as well as fat. Oral GH-secretagogue therapy has been shown to improve body composition in older adults by supporting lean mass,[6 which is one reason peptides are sometimes paired with GLP-1 programs. Progress is best tracked with a DEXA body-composition scan that separates fat loss from lean-mass loss, and patients focused on building muscle can review our guide to peptides for muscle growth.

How Weight-Loss Protocols Are Designed

Strong Health weight-loss protocols start with a physician evaluation, metabolic labs, and a body-composition baseline. Medication choice, dose titration, and any peptide pairing are individualized and monitored on a schedule. Beyond weight, GLP-1 therapy has been associated with cardiovascular benefit in people with obesity and without diabetes.[7 Locally, our medical weight-loss clinic in Miami designs and supervises these programs.

Safety and Side Effects

GLP-1 medications most commonly cause gastrointestinal side effects such as nausea, which usually ease with gradual dose titration. GH-secretagogue peptides are generally well tolerated under supervision, with contraindications including active malignancy and certain endocrine disorders. Every protocol requires physician oversight and ongoing monitoring. Explore all options in our peptide therapy hub.